author-photo

Philippe Laplaige

31

Papers

106

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment.

2021 BMJ
Show All
- Source
- Cite
- Save
Citations (0)
Hot-clot artifact in the lung parenchyma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography mimicking malignancy with a homolateral non-small cell lung cancer

2021 World journal of nuclear medicine
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (>/=75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study.

2020 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Costs of renewable and recovery energies in France; Data 2019

2020
Show All
- Source
- Cite
- Save
Citations (0)
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (39)
549PImpact of concomitant medications on disease free survival (DFS) and overall survival (OS) in patients from the PETACC8 study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (28)
First-line (1-L) bevacizumab plus chemotherapy (Bev/CT) in colorectal cancer (CRC) patients with potentially resectable liver only (LM) or liver and lung metastases (LLM): KRAS mutation analysis of the non-interventional PICASSO study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab plus chemotherapy (bev/CT) as first-line therapy for patients with potentially resectable metastatic colorectal cancer (mCRC): Final results of the French noninterventional PICASSO study.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Aflibercept in combination with FOLFIRI for the second-line treatment of patients with metastatic colorectal cancer: First interim safety data from AFEQT trial.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)